Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1991 1
1994 1
1997 1
2000 2
2001 1
2002 2
2003 2
2004 3
2005 4
2006 2
2007 3
2008 1
2009 1
2010 4
2011 2
2012 3
2013 5
2014 3
2015 5
2016 5
2017 3
2018 3
2019 3
2020 2
2021 2
2022 5
2023 3
2024 2
2025 7
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
A comprehensive review and update on ulcerative colitis().
Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. Gajendran M, et al. Dis Mon. 2019 Dec;65(12):100851. doi: 10.1016/j.disamonth.2019.02.004. Epub 2019 Mar 2. Dis Mon. 2019. PMID: 30837080 Review.
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that causes continuous mucosal inflammation extending from the rectum to the more proximal colon, with variable extents. ...UC was first described by Samuel Wilks in 1859 and it
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that causes continuous mucosal inflam
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'Haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV Jr, Marteau P, Munkholm P, Murdoch TB, Ordás I, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, Panes J, Bouguen G, O'Donnell S, Pariente B, Winer S, Hanauer S, Colombel JF. Peyrin-Biroulet L, et al. Am J Gastroenterol. 2015 Sep;110(9):1324-38. doi: 10.1038/ajg.2015.233. Epub 2015 Aug 25. Am J Gastroenterol. 2015. PMID: 26303131
RESULTS: The group agreed upon 12 recommendations for ulcerative colitis (UC) and Crohn's disease (CD). The agreed target for UC was clinical/patient-reported outcome (PRO) remission (defined as resolution of rectal bleeding and diarrhea/altered …
RESULTS: The group agreed upon 12 recommendations for ulcerative colitis (UC) and Crohn's disease (CD). T …
Gastrointestinal Conditions: Inflammatory Bowel Disease.
Davis J, Kellerman R. Davis J, et al. FP Essent. 2022 May;516:23-30. FP Essent. 2022. PMID: 35507310
IBDs, which affect 1.3% of Americans, include Crohn disease (CD), ulcerative colitis (UC), and microscopic colitis. UC and microscopic colitis are limited to the colon, but CD can occur anywhere along the gastrointestinal tract. ...Howeve …
IBDs, which affect 1.3% of Americans, include Crohn disease (CD), ulcerative colitis (UC), and microscopic co
Accuracy of abdominal ultrasound and MRI for detection of Crohn disease and ulcerative colitis in children.
Ziech ML, Hummel TZ, Smets AM, Nievelstein RA, Lavini C, Caan MW, Nederveen AJ, Roelofs JJ, Bipat S, Benninga MA, Kindermann A, Stoker J. Ziech ML, et al. Pediatr Radiol. 2014 Nov;44(11):1370-8. doi: 10.1007/s00247-014-3010-4. Epub 2014 Jun 6. Pediatr Radiol. 2014. PMID: 24903659
BACKGROUND: Endoscopy is currently the primary diagnostic technique for inflammatory bowel disease (IBD) in children. OBJECTIVE: To assess the accuracy of US and dynamic contrast-enhanced MRI for diagnosing inflammatory bowel disease and for distinguishing Crohn
BACKGROUND: Endoscopy is currently the primary diagnostic technique for inflammatory bowel disease (IBD) in children. OBJECTIVE: To a …
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
Schreiber S, Lee SD, van der Woude CJ, Marín-Jiménez I, Wolf DC, Schnoy E, Salzberg B, Busse C, Nazar M, Ma T, Borghorst S, Gasink C, Baker T, Godwin B, Adedokun OJ, Feagan BG; POWER Study Group. Schreiber S, et al. Inflamm Bowel Dis. 2025 Dec 1;31(12):3286-3297. doi: 10.1093/ibd/izaf163. Inflamm Bowel Dis. 2025. PMID: 40971924 Free PMC article. Clinical Trial.
BACKGROUND: The POWER study (NCT03782376) evaluated efficacy and safety of a single ustekinumab intravenous (IV) reinduction dose versus placebo under continued ustekinumab subcutaneous (SC) treatment in adult patients with moderately to severely active Crohn's d
BACKGROUND: The POWER study (NCT03782376) evaluated efficacy and safety of a single ustekinumab intravenous (IV) reinduction dose versus pla …
Role of endoscopy in inflammatory bowel disease.
Bharadwaj S, Narula N, Tandon P, Yaghoobi M. Bharadwaj S, et al. Gastroenterol Rep (Oxf). 2018 May;6(2):75-82. doi: 10.1093/gastro/goy006. Epub 2018 Mar 9. Gastroenterol Rep (Oxf). 2018. PMID: 29780594 Free PMC article. Review.
Crohn's disease (CD) and ulcerative colitis (UC) constitute the two most common phenotypes of inflammatory bowel disease (IBD). Ileocolonoscopy with biopsy has been considered the gold standard for the diagnosis of IBD. ...
Crohn's disease (CD) and ulcerative colitis (UC) constitute the two most common phenotypes of inflammator
Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E, Kelly OB, Kirsch R, Milgrom R, Burns J, Nguyen GC, Croitoru K, Van Assche G, Silverberg MS, Steinhart AH. Zittan E, et al. Inflamm Bowel Dis. 2016 Mar;22(3):623-30. doi: 10.1097/MIB.0000000000000652. Inflamm Bowel Dis. 2016. PMID: 26829408
We examined how FC levels correlate with histological and endoscopic remission in colonic inflammatory bowel disease. METHODS: Fifty-eight patients (23 with colonic Crohn's disease [CD] and 35 with ulcerative colitis [UC]) were included. …
We examined how FC levels correlate with histological and endoscopic remission in colonic inflammatory bowel disease. METHODS: Fifty- …
Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort study.
Rodríguez-Lago I, Marigorta UM, Mateos B, Mañosa M, Márquez-Mosquera L, Menchén L, Rodríguez-Moranta F, Alonso I, Aguas M, Alonso-Galán H, Borràs P, Castro B, Domènech E, Ferreiro-Iglesias R, de Francisco R, García-Alonso FJ, García N, García-Bosch O, Gargallo C, Gisbert JP, Iglesias E, Mesonero F, Ortiz de Zárate J, Ramos L, Sáinz E, Ladrón P, Suria C, Ferrer CS, Tejido C, Varela P, Vicente R, Zabana Y, Castany G, Rodríguez E, Gutiérrez A, Barreiro-de Acosta M. Rodríguez-Lago I, et al. Ther Adv Gastroenterol. 2025 May 12;18:17562848251338647. doi: 10.1177/17562848251338647. eCollection 2025. Ther Adv Gastroenterol. 2025. PMID: 40365077 Free PMC article.
BACKGROUND: The period prior to the diagnosis of inflammatory bowel disease (IBD), defined as the preclinical phase, has emerged as a potential target for disease modification strategies. ...Study protocol of a study on the natural history, immunological and genetic …
BACKGROUND: The period prior to the diagnosis of inflammatory bowel disease (IBD), defined as the preclinical phase, has emerged as a …
Performance of GPT-5 in the Interpretation of IBD Histopathology Reports.
Maida M, Vitello A, Macaluso FS, Daperno M, Mocci G, Rispo A, Calabrese G, Decarli NL, Laschi L, Fattorini C, Locci G, Sordo RD, Ligresti D, Tacelli M, Furnari M, Sferrazza S, Marasco G, Facciorusso A, Orlando A, Villanacci V. Maida M, et al. United European Gastroenterol J. 2026 Feb;14(1):e70161. doi: 10.1002/ueg2.70161. Epub 2025 Dec 17. United European Gastroenterol J. 2026. PMID: 41404996 Free PMC article.
BACKGROUND: Histopathological interpretation is crucial for diagnosing inflammatory bowel disease (IBD), distinguishing between Crohn's Disease (CD), Ulcerative Colitis (UC), IBD-Unclassified (IBD-U), and Non-IBD colitis (NIBDC). . …
BACKGROUND: Histopathological interpretation is crucial for diagnosing inflammatory bowel disease (IBD), distinguishing between Cr
Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores.
Rodrigues BL, Mazzaro MC, Nagasako CK, Ayrizono MLS, Fagundes JJ, Leal RF. Rodrigues BL, et al. World J Gastrointest Endosc. 2020 Dec 16;12(12):504-520. doi: 10.4253/wjge.v12.i12.504. World J Gastrointest Endosc. 2020. PMID: 33362904 Free PMC article. Review.
Inflammatory bowel diseases (IBD) comprise two major forms: Crohn's disease and ulcerative colitis. The diagnosis of IBD is based on clinical symptoms combined with results found in endoscopic and radiological examinations. ...Several potential …
Inflammatory bowel diseases (IBD) comprise two major forms: Crohn's disease and ulcerative colitis. The d …
76 results